Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein Occlusion

NCT06416241 is registered in ClinicalTrials.gov with University of Athens as lead sponsor.

NCT NCT06416241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06416241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein Occlusion
Lead sponsor
University of Athens
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2017
Completion date
March 31, 2024
Enrollment
51 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

retinal vein occlusion, vascular occlusive disease